Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | BAX | Q07812 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3064538 | 1.00 | LMNA (0.62) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3052608 | 0.82 | LMNA (0.65) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3052606 | 0.82 | LMNA (0.65) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL16856039 | 0.82 | KMT2A (0.60) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL20263737 | 0.82 | KMT2A (0.60) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3047604 | 0.81 | CYP19A1 (0.54) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3047598 | 0.81 | CYP19A1 (0.54) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3064530 | 0.81 | LMNA (0.58) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| SCHEMBL3064531 | 0.81 | LMNA (0.58) | LMNAKMT2AGFERL3MBTL1PARP10 | |
| Benzamidoxime SCHEMBL30242 | 0.80 | KMT2A (0.58) | KMT2AL3MBTL1GAARAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423486-B1 | — | — | None | — | — | US | disclosed |
| US-20230091947-A1 | ALTERNATING CURRENT ELECTROLYSIS FOR USE IN ORGANIC SYNTHESIS | WAYNE STATE UNIVERSITY (US) | 2023-03-23 | — | — | US | disclosed |
| US-20210207274-A1 | ALTERNATING CURRENT ELECTROLYSIS FOR USE IN ORGANIC SYNTHESIS | WAYNE STATE UNIVERSITY (US) | 2021-07-08 | — | — | US | disclosed |
| US-9045442-B2 | Antibacterial compounds and methods of using same | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2015-06-02 | — | — | US | disclosed |
| US-20150133495-A1 | Substituted Acyloxyamidines as HCV NS3/4A Inhibitors | VIROCURA THERAPEUTICS INC (CA) | 2015-05-14 | — | — | US | disclosed |
| US-8877515-B2 | Measurement kit and an immunochromatography method | FUJIFILM CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-8835182-B2 | Immunochromatographic device | FUJIFILM CORPORATION (JP) | 2014-09-16 | — | — | US | disclosed |
| EP-2042871-B1 | Method for mixing two or more types of liquids in porous carrier | FUJIFILM CORP (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20130137190-A1 | IMMUNOCHROMATOGRAPHIC DEVICE | FUJIFILM CORPORATION (JP) | 2013-05-30 | — | — | US | disclosed |
| US-8383422-B2 | Immunochromatographic device | FUJIFILM CORPORATION (JP) | 2013-02-26 | — | — | US | disclosed |
| US-5196301-A | 3-substituted-5-alkylthio-1,2,4-triazoles | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-03-23 | — | — | US | disclosed |
| US-5175081-A | Post-processsing stabilization of photothermographic emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-12-29 | — | — | US | disclosed |
| US-5158866-A | POST-PROCESSING STABILIZATION OF PHOTOTHERMOGRAPHIC EMULSIONS WITH AMIDO COMPOUNDS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| US-5149620-A | 5-mercapto-1,2,4-triazole derivatives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0480568-A2 | Post-processing stabilization of photothermographic emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0473351-A2 | Post-processing stabilization of photothermographic emulsions with amido compounds | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-03-04 | — | — | EP | disclosed |
| WO-1992002852-A1 | POST-PROCESSING STABILIZED PHOTOTHERMOGRAPHIC EMULSIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-02-20 | — | — | WO | disclosed |
| WO-1992002853-A1 | POST-PROCESSING STABILIZATION OF PHOTOTHERMOGRAPHIC EMULSIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-02-20 | — | — | WO | disclosed |
| US-4923792-A | BENZYLIDENE LEUCO COMPOUNDS AS COLOR-GENERATING REDUCING AGENTS, TOPCOAT OF POLYVINYL ALCOHOL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-05-08 | — | — | US | disclosed |
| US-4883747-A | LIGHT SENSITIVE SILVER HALIDE, ORGANIC ACID SILVER SALT, LEUCO DYE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133495-A1 | Substituted Acyloxyamidines as HCV NS3/4A Inhibitors | EIF2AK2, GTF3C4, GTF3C1 | LMNA 4687/4885KMT2A 1919/4885GFER 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.